Prosecution Insights
Last updated: July 05, 2026

Board of Regents of the University of Oklahoma

19 pending office actions • 16 art units • 18 examiners • 0 of 19 (0%) have an AI response strategy ready • 16 patents granted in the last 365 days

Portfolio Summary

19
Total Pending OAs
14
Non-Final OAs
5
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 13 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

10
Overdue
0
Due this week
1
Due this month
1
Due in next 60 days
1
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 13 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (10)Due ≤ 30 days (1)Due ≤ 60 days (1)Due later (1)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
16
Medium (84%)
3
Easy (16%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§103 only14 (74%)
§102 only2 (11%)
§112 only2 (11%)
Double-patenting only1 (5%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

10
Life Sciences
53% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
4
Semiconductors
21% of docket
4
Mechanical / Eng
21% of docket
1
Business / Other
5% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

190 h
Manual time on pending OAs
38 h
Time saved (low, 20%)
66 h
Time saved (mid, 35%)
1.7 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
ELENISTE, PIERRE PAUL 2 36.6% +32.2%
MCCULLOUGH, ERIC J. 1 31.4% +43.5%
TAN, DING Y 1 75.8% +17.4%
AMARA, MOHAMED K 1 75.7% +30.0%
SCHINDLER, DAVID M 1 40.9% +23.2%
VARADARAJ, ARCHANA 1 100.0% +0.0%
RUNYAN, SILVANA C 1 82.3% +17.2%
BORALSKY, LUKE ALAN 1 100.0% +0.0%
SEITZ, ANTHONY JOSEPH 1 67.2% +26.2%
KATAKAM, SUDHAKAR 1 75.1% +22.9%

Quick Wins (3)

Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 3 ordered by deadline are shown.

App #TitleExaminerDue in
18422556 METHODS OF TREATING TRAUMATIC BRAIN INJURY AND RELATED NEUROLOGICAL CONDITIONS VARADARAJ, ARCHANA
18407624 SMART NANOFLUIDS FOR GEOTHERMAL APPLICATIONS AND METHODS OF USE RUNYAN, SILVANA C
18543655 ISOMEROHYDROLASE INHIBITOR FOR TREATMENT OF ATROPHIC FORM OF AGE-RELATED MACULAR DEGENERATION AND STARGARDT DISEASE BORALSKY, LUKE ALAN

Interview Candidates (9)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18444665 System and Method for Locating Undocumented Orphaned Oil and Gas Wells with a Smartphone SCHINDLER, DAVID M 155d overdue
18383708 PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA (PPARy) LIGANDS AND METHODS OF USE AS TREATMENTS FOR INSULIN RESISTANCE, OBESITY, FATTY LIVER DISEASE, AND TYPE 2 DIABETES SEITZ, ANTHONY JOSEPH 132d overdue
17276032 COMBINATION CANCER THERAPIES ELENISTE, PIERRE PAUL 74d overdue
18873924 ZINC IMIDAZOLE SALICYLALDOXIME-BASED ADSORPTIVE MEMBRANES FOR REMOVAL OF METAL IONS FROM AQUEOUS SOLUTIONS MCCULLOUGH, ERIC J. 42d overdue
18101627 COMBINATION CANCER THERAPIES ELENISTE, PIERRE PAUL 9d overdue
18904698 SYSTEM FOR MOUNTING SOLAR PANELS TAN, DING Y 62d
18611339 APPARATUS FOR TIME-RESOLVED FLUORESCENCE MEASUREMENT USING BANDWIDTH-LIMITED DIGITAL-PULSE LIGHT MODULATION AND METHODS AMARA, MOHAMED K
18407624 SMART NANOFLUIDS FOR GEOTHERMAL APPLICATIONS AND METHODS OF USE RUNYAN, SILVANA C

Top Art Units

Art UnitApps
1622 3
1773 1
3632 1
2877 1
2858 1
3678 1
1624 1
1629 1
1658 1
3700 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18873924 ZINC IMIDAZOLE SALICYLALDOXIME-BASED ADSORPTIVE MEMBRANES FOR REMOVAL OF METAL IONS FROM AQUEOUS SOLUTIONS MCCULLOUGH, ERIC J. 1773 §103 Non-Final OA 42d overdue Pending Dec 11, 2024
18904698 SYSTEM FOR MOUNTING SOLAR PANELS TAN, DING Y 3632 §102 Non-Final OA 62d Pending Oct 02, 2024
18611339 APPARATUS FOR TIME-RESOLVED FLUORESCENCE MEASUREMENT USING BANDWIDTH-LIMITED DIGITAL-PULSE LIGHT MODULATION AND METHODS AMARA, MOHAMED K 2877 §103 Final Rejection Pending Mar 20, 2024
18444665 System and Method for Locating Undocumented Orphaned Oil and Gas Wells with a Smartphone SCHINDLER, DAVID M 2858 §103 Final Rejection 155d overdue Pending Feb 17, 2024
18422556 METHODS OF TREATING TRAUMATIC BRAIN INJURY AND RELATED NEUROLOGICAL CONDITIONS VARADARAJ, ARCHANA DP Non-Final OA Pending Jan 25, 2024
18407624 SMART NANOFLUIDS FOR GEOTHERMAL APPLICATIONS AND METHODS OF USE RUNYAN, SILVANA C 3678 §112 Non-Final OA Pending Jan 09, 2024
18543655 ISOMEROHYDROLASE INHIBITOR FOR TREATMENT OF ATROPHIC FORM OF AGE-RELATED MACULAR DEGENERATION AND STARGARDT DISEASE BORALSKY, LUKE ALAN 1624 §103 Non-Final OA Pending Dec 18, 2023
18383708 PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA (PPARy) LIGANDS AND METHODS OF USE AS TREATMENTS FOR INSULIN RESISTANCE, OBESITY, FATTY LIVER DISEASE, AND TYPE 2 DIABETES SEITZ, ANTHONY JOSEPH 1629 §103 Non-Final OA 132d overdue Pending Oct 25, 2023
18280351 SELF-ASSEMBLING PEPTIDES, NANOFIBERS, AND METHODS OF USE KATAKAM, SUDHAKAR 1658 §112 Non-Final OA Pending Sep 05, 2023
18037706 Apparatus and Method for Capturing Aerosols WILSON, KAYLEE R 3700 §103 Non-Final OA 15d overdue Pending May 18, 2023
18101627 COMBINATION CANCER THERAPIES ELENISTE, PIERRE PAUL 1622 §103 Non-Final OA 9d overdue Pending Jan 26, 2023
18004479 Biomarkers for Identifying Relapses in Multiple Sclerosis FONTAINHAS, AURORA M 1675 §103 Non-Final OA 17d overdue Pending Jan 06, 2023
18081495 PRODUCING RADIOPHARMACEUTICAL COLD KITS WITHOUT LYOPHILIZATION SCHLIENTZ, LEAH H 1618 §103 Non-Final OA Pending Dec 14, 2022
17971072 MICROBIOME TRANSPLANTATION FOR OSTEOARTHRITIS THERAPY CRUM, MARY ABOU NADER 1657 §103 Final Rejection 34d Pending Oct 21, 2022
17802423 Medicine Dispenser with Patient Compliance Monitoring System KUMAR, RAKESH 3651 §102 Non-Final OA 53d overdue Pending Aug 25, 2022
17821039 Interband Cascade Infrared Photodetectors and Methods of Use SARKER-NAG, AKHEE 2893 §103 Non-Final OA 29d Pending Aug 19, 2022
17684202 Multi-Bandgap Charge-Coupled Device (CCD) BULLARD-CONNOR, GENEVIEVE GRACE 2899 §103 Final Rejection 73d overdue Pending Mar 01, 2022
17534888 SHIKIMATE ANALOGUES AND METHODS OF USE SOROUSH, LAYLA 1622 §103 Final Rejection 53d overdue Pending Nov 24, 2021
17276032 COMBINATION CANCER THERAPIES ELENISTE, PIERRE PAUL 1622 §103 Non-Final OA 74d overdue Pending Mar 12, 2021

Managing Board of Regents of the University of Oklahoma's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month